Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | ACVR1 | Q04771 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.36 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.36 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.36 |
| ▸ | GLS | O94925 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12839074 | 0.91 | ROCK1 (0.40) | ALDH1A1NPC1RAB9AKMT2AMEN1 | |
| SCHEMBL12840037 | 0.90 | KMT2A (0.45) | ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A | |
| SCHEMBL12839086 | 0.90 | ACVR1 (0.37) | ALDH1A1NPC1RAB9AKMT2AMEN1 | |
| SCHEMBL13067575 | 0.90 | RORC (0.41) | ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A | |
| SCHEMBL12839948 | 0.90 | NPC1 (0.43) | ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A | |
| SCHEMBL12839675 | 0.90 | TMIGD3 (0.43) | ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A | |
| SCHEMBL12839058 | 0.87 | MAPK1 (0.41) | ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A | |
| SCHEMBL12839087 | 0.85 | CACNA1H (0.42) | RAB9AKMT2AMEN1MAPK8 | |
| SCHEMBL12839536 | 0.85 | ROCK1 (0.43) | ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A | |
| SCHEMBL12840039 | 0.84 | KMT2A (0.49) | ALDH1A1SMN1; SMN2NPC1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110070656-A1 | Fluorescent Proteins | JNC CORPORATION (JP) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110070656-A1 | Fluorescent Proteins | CACYBP, CHLSN, LCP2 | ALDH1A1 4516/4885SMN1; SMN2 4784/4885NPC1 2936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.